Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
[Affective and psychotic disorders in multiple sclerosis].
Paracaspase MALT1 Deficiency Protects Mice from Autoimmune-Mediated Demyelination.
Rat Cortical Oligodendrocyte-Embryonic Motoneuron Co-Culture: An In Vitro Axon-Oligodendrocyte Interaction Model.
Diffusion tensor imaging of extraocular muscle using two-dimensional single-shot interleaved multiple inner volume imaging diffusion-weighted EPI at 3 tesla.
Transcriptional expression of MBP in oligodendrocytes depends on functional syntaxin 4; a potential correlation with autocrine signalling.
Heterogeneity of oligodendrocyte progenitor cells in adult human brain.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice.
Effect of short-term interferon-β treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23.
Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals.
Detecting clinically-relevant changes in progressive multiple sclerosis.
Analyzing differences between patient and proxy on Patient Reported Outcomes in multiple sclerosis.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Perception of affective prosody in patients at an early stage of relapsing-remitting multiple sclerosis.
Vitamin D and multiple sclerosis: timing of sampling, treatment and prevention.
LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis.
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Epstein Barr virus infection reactivation as a possible trigger of primary biliary cirrhosis-like syndrome in a patient with multiple sclerosis in the course of fingolimod treatment.
c-kit plays a critical role in induction of intravenous tolerance in experimental autoimmune encephalomyelitis.
The high cost of spasticity in multiple sclerosis to individuals and society.
Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis.
[Treatment of nausea and vomiting with prokinetics and neuroleptics in palliative care patients : A review.]
Anti-aquaporin-4 IgG in Patients Presenting with Unilateral Optic Neuritis: A Cohort Study.
Role of serine proteases in inflammation: Bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases.
Pages
« first
‹ previous
…
318
319
320
321
322
323
324
325
326
…
next ›
last »